Ultra-high-risk choriocarcinoma with atraumatic splenic rupture: a rare case report

Choriocarcinoma is a malignant tumor associated with early vascular invasion and a high mortality. Ultra-high-risk choriocarcinoma, which was proposed in the International Federation of Gynecology and Obstetrics cancer report of 2018, has a higher risk of treatment failure and a worse prognosis than choriocarcinoma. We report a rare case of a 39-year-old female patient with ultra-high-risk choriocarcinoma (stage IV:20) with hemorrhage secondary to atraumatic splenic rupture as the initial sign. A satisfactory outcome was achieved through comprehensive treatment with surgery, chemotherapy, immunotherapy, and targeted therapy.

[1]  J. Yang,et al.  [Preliminary study of PD-1 inhibitor in the treatment of drug-resistant recurrent gestational trophoblastic neoplasia]. , 2020, Zhonghua fu chan ke za zhi.

[2]  Jun Li,et al.  Chemotherapy for gestational trophoblastic neoplasia patients with a FIGO score of 12 or greater: A multistudy analysis. , 2019, European journal of obstetrics, gynecology, and reproductive biology.

[3]  V. Shelat,et al.  Laparoscopic splenectomy for splenic rupture secondary to metastatic choriocarcinoma , 2018, Annals of hepato-biliary-pancreatic surgery.

[4]  S. Brouillet,et al.  Antagonism of EG-VEGF Receptors as Targeted Therapy for Choriocarcinoma Progression In Vitro and In Vivo , 2017, Clinical Cancer Research.

[5]  Jubilee Brown,et al.  15years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage. , 2017, Gynecologic oncology.

[6]  A. Schott,et al.  Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13. , 2016, American journal of obstetrics and gynecology.

[7]  T. Fehm,et al.  Gestational Trophoblastic Disorders: An Update in 2015. , 2015, Geburtshilfe und Frauenheilkunde.

[8]  R. Berkowitz,et al.  Update on the diagnosis and management of gestational trophoblastic disease , 2018, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[9]  M. Seckl,et al.  Successful embolisation of a life threatening bleeding splenic metastasis in a patient with gestational choriocarcinoma , 2015 .

[10]  Junjun Yang,et al.  Analysis of the Prognosis and Related Factors for Patients With Stage IV Gestational Trophoblastic Neoplasia , 2014, International Journal of Gynecologic Cancer.

[11]  David Moher,et al.  The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development , 2013, Journal of Medical Case Reports.

[12]  J. Hawe,et al.  Splenic rupture: a rare presentation of metastatic choriocarcinoma , 2011, Gynecological Surgery.

[13]  Y. Xiang,et al.  Clinical parameters predicting therapeutic response to surgical management in patients with chemotherapy-resistant gestational trophoblastic neoplasia. , 2009, Gynecologic oncology.

[14]  N. Tuzuner,et al.  Gestational choriocarcinoma diagnosed with spontaneous splenic rupture after pregnancy induced by in vitro fertilization: a case report , 2009, Cases journal.

[15]  D. Jackson,et al.  Choriocarcinoma of the spleen--a rare cause of atraumatic rupture. , 2008, Annals of the Royal College of Surgeons of England.

[16]  J. Benedet,et al.  Gestational trophoblastic neoplasia, FIGO 2000 staging and classification , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[17]  S. Steigrad,et al.  Choriocarcinoma Complicated by Splenic Rupture: An Unusual Presentation , 1996, The journal of obstetrics and gynaecology research.